UC Davis Multi-Disciplinary Cancer Research Training Program to Advance Precision Cancer Prevention and Care in Latin America.
UC Davis Multi-Disciplinary Cancer Research Training Program to Advance Precision Cancer Prevention and Care in Latin America.
批准号:
10438437
负责人:
Luis Guillermo Carvajal Carmona
金额:
$27.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
AddressAgeAmericanAreaBasic ScienceBioinformaticsCancer BurdenCancer CenterCancer ControlCessation of lifeClinicalClinical OncologyCollaborationsColombiaColombianComplementCountryDemographyDevelopmentEducational CurriculumEthicsEuropeanFoundationsFundingFunding OpportunitiesGoalsHealthcareHomeIndividualInfection ControlInstitutionKnowledgeLatin AmericaLatin AmericanLatino PopulationLeadLife ExpectancyMalignant NeoplasmsMentorsMutationNational Cancer InstituteOncologyPatientsPeruPeruvianPhysiciansPopulationPrecision therapeuticsPrincipal InvestigatorProviderReportingResearchResearch PersonnelResearch Project GrantsResearch SupportResource DevelopmentResourcesRisk AssessmentSolidTrainingTraining ProgramsUnited States National Institutes of HealthUniversitiesanticancer researchbasebiobankcancer carecancer epidemiologycancer geneticscancer riskcancer therapycloud basedexperiencegraduate studenthealth care availabilityhuman capitalindividualized preventionlow and middle-income countriesmultidisciplinarypre-clinicalprecision cancer preventionprecision oncologyprogramsskillstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Improvements in health care access and infection control have led to life expectancy increases in Low- and
Middle-Income Countries (LMICs) in Latin America. As the population ages, the Latin American cancer burden
has dramatically increased. By 2030, Latin America is expected to have annual averages of 1.6M new cancer
cases and 1M cancer deaths. A Latin America Lancet Oncology Commission report highlighted the small
amount of preclinical and clinical oncology research originating in the region as a limitation to control cancer
burden. Colombia and Peru, the Latin American LMICs with the first and second largest populations, have
state-funded national cancer institutes (NCIs) that are cancer treatment reference centers, and which lead
national efforts in cancer control and care. However, cancer risk assessment and patient treatment at these
institutions is primarily based on tools developed in North American and European patients. Despite having
exceptional researchers and physicians, most cancer centers in Latin America lack training programs that
would allow them to develop or adapt precision prevention or treatment tools that are appropriate to the
ancestry or mutation profiles of individuals from the region. The current funding opportunity is the ideal
program to formalize and enhance ongoing collaborations between US-based healthcare researchers and
providers in Colombia and Peru. It will provide a solid foundation for precision oncology research knowledge
transfer and to build local human capital necessary to develop precision cancer medicine in Latin America.
Building on our extensive expertise on Latin American population demography, cancer epidemiology and
genetics, NIH funded cancer studies in Latino populations, and a strong track record of research collaboration
and training with Colombian and Peruvian researchers, the overall goals of the UC Davis Multidisciplinary
Cancer Research Training Program to Advance Precision Cancer Prevention and Care in Latin America are to:
1) Enhance local capacity for precision cancer medicine research in Colombia and Peru by implementing a
curriculum that complements and addresses gaps in local training programs and provides hands on experience
and support for research project development relevant to the region, 2) Provide hands on training on research
resource development including ethics training, biobanking best practices, and cloud-based bioinformatics; and
3) allocate pilot funding for mentored research for basic science and clinically-oriented term trainees. We
propose to establish a curriculum to train graduate students and postdoctoral/clinical fellows in precision
oncology research. We will prepare trainees to implement and share their new skills in their home countries
and to collaborate with U.S-based investigators. We will leverage ongoing collaborations among the program
Principal Investigators, universities, and NCIs of Colombia and Peru to identify relevant areas of research that
could be enhanced by the training program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of California and UT Southwestern D-PDTC
-
批准号:10733391
-
项目类别:
-
资助金额:$106.11万
-
财政年份:2023
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Admin Core
-
批准号:10733392
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2023
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Advancing gastric cancer precision medicine in Latinos through patient-derived modeling
-
批准号:10733395
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2023
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Preclinical studies of KRAS and EGFR mutations in lung cancer PDXs
-
批准号:10582478
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2022
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Bridges to Doctorate Program between Fresno State and UC Davis
-
批准号:10674976
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2020
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Bridges to Doctorate Program between Fresno State and UC Davis
-
批准号:10223383
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2020
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Bridges to Doctorate Program between Fresno State and UC Davis
-
批准号:10024812
-
项目类别:
-
资助金额:$12.36万
-
财政年份:2020
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Bridges to Doctorate Program between Fresno State and UC Davis
-
批准号:10454971
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2020
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Development of Research And Writing Skills (DRAWS): A tool for broader assessment to enhance research and research training
-
批准号:10393926
-
项目类别:
-
资助金额:$0.67万
-
财政年份:2020
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
-
批准号:10011077
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2018
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Genetic studies of homologous recombination deficiency in hispanic gastric cancer
-
批准号:10172867
-
项目类别:
-
资助金额:$52.7万
-
财政年份:2018
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Genetic studies of homologous recombination deficiency in hispanic gastric cancer
-
批准号:10411392
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2018
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Genetic studies of homologous recombination deficiency in hispanic gastric cancer
-
批准号:10425289
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2018
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Genetic studies of homologous recombination deficiency in hispanic gastric cancer
-
批准号:10524102
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2018
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
-
批准号:9905142
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2018
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Genetic studies of homologous recombination deficiency in hispanic gastric cancer
-
批准号:10578426
-
项目类别:
-
资助金额:$5.91万
-
财政年份:2018
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
Dissecting gastric cancer clonality with genomic analyses and patient xenografts
-
批准号:9188431
-
项目类别:
-
资助金额:$17.07万
-
财政年份:2016
-
负责人:Luis Guillermo Carvajal Carmona
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: